Skip to main content
. 2008 Jul 14;52(9):3339–3349. doi: 10.1128/AAC.00496-08

FIG. 4.

FIG. 4.

MICs (mg liter−1) of levofloxacin (LVX) (A) and moxifloxacin (MFX) (B) against the S. aureus Bontemps mutant strain possessing, at day 1, a substitution of lysine for methionine at gyrase A primary structure position 121. Squares, fluoroquinolone; triangles, NXL101.